Department of Gynaecology, Sandwell and West Birmingham Hospitals NHS Trust (SWBH), Birmingham, UK.
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
J Obstet Gynaecol. 2022 Aug;42(6):2474-2479. doi: 10.1080/01443615.2022.2074787. Epub 2022 Jun 10.
Maternity statistics of England in 2020 showed rise in Caesarean Section (CS) rate to 31%. Some studies correlated adverse gynaecological symptoms e.g. menstrual irregularities and pelvic pain to 'niche' formation at CS scar site. Niche formation was speculated to cause myometrial hypertrophy aggravating these symptoms. This was a prospective comparative histological study including 52 consecutive benign hysterectomy specimens which were categorised into 2 groups: (i) specimens with CS scar ( = 22), (ii) specimens with no CS scar ( = 30). Median (IQ range) uteri weight was 97.2grms (43.5-226) and 91.7grms (35.7-201.7) in study and control groups, respectively ( = .991). Mean (±SD) thickness of anterior myometrial wall was 18.7 mm (±3.6) and 19.4 mm (±4.5) in study and control groups, respectively ( = .58). Mean (±SD) thickness of posterior myometrial wall was 19.1 mm (±3.7) and 18.7 mm (±3.9) in study and control groups, respectively ( = .78). The assumption that CS scar causes myometrial hypertrophy was not demonstrated in this study.IMPACT STATEMENT Maternity statistics world-wide show a continuous rise in the rate of Caesarean Section (CS) operation. The CS scar is assumed to be related to adverse clinical gynaecological symptoms such as intermenstrual bleeding, dysmenorrhoea, dyspareunia and chronic pelvic pain; however, the mechanism of this association is not clear. Further, little is known about the effects of CS scar on uterine wall morphology and function. This study was the first prospective series in the literature to compare the uteri with scar with those without in respect of weight and myometrial wall thickness. It was not able to demonstrate the association between having CS scar and myometrial hypertrophy which was hypothesised to be the cause of adverse gynaecological symptoms. However, the microscopic examination of the CS scar revealed adenomyosis, haemorrhage and/or chronic inflammation in most cases. The clinical implication of the histological changes shown in the CS scar requires large comparative clinical studies.
2020 年英格兰的产妇统计数据显示,剖宫产率上升至 31%。一些研究将不良妇科症状(如月经不规律和盆腔疼痛)与剖宫产疤痕部位的“龛”形成相关联。有人推测,龛的形成会导致子宫肌层肥大,加重这些症状。这是一项前瞻性对比组织学研究,包括 52 例连续的良性子宫切除术标本,分为 2 组:(i)有剖宫产疤痕的标本( = 22),(ii)无剖宫产疤痕的标本( = 30)。研究组和对照组的子宫重量中位数(IQR 范围)分别为 97.2 克(43.5-226)和 91.7 克(35.7-201.7)( = .991)。前壁子宫肌层的平均(±SD)厚度分别为 18.7 mm(±3.6)和 19.4 mm(±4.5)( = .58)。后壁子宫肌层的平均(±SD)厚度分别为 19.1 mm(±3.7)和 18.7 mm(±3.9)( = .78)。在这项研究中,没有证明剖宫产疤痕会导致子宫肌层肥大的假设。
世界范围内的产妇统计数据显示,剖宫产率持续上升。有人假设剖宫产疤痕与不良妇科症状(如月经间期出血、痛经、性交困难和慢性盆腔疼痛)有关;然而,这种关联的机制尚不清楚。此外,人们对剖宫产疤痕对子宫壁形态和功能的影响知之甚少。这是文献中首次比较有疤痕和无疤痕子宫的前瞻性系列研究。它未能证明有剖宫产疤痕与子宫肌层肥大之间的关联,而子宫肌层肥大被假设为不良妇科症状的原因。然而,大多数情况下,剖宫产疤痕的组织学检查显示腺肌病、出血和/或慢性炎症。需要进行大型的对比临床研究来了解剖宫产疤痕显示的组织学变化的临床意义。